From Business Insider · Truman Dickerson · · 1m 50s
Amodei's cancer cure claim draws fire from doctors
Anthropic CEO Dario Amodei predicted AI will cure cancer and Alzheimer's in a decade during an IPO roadshow. Medical experts and biotech leaders say the timeline is unrealistic and the claim is hype.
In brief
Anthropic CEO Dario Amodei predicted AI will cure cancer and Alzheimer's in a decade during an IPO roadshow. Medical experts and biotech leaders say the timeline is unrealistic and the claim is hype. Anthropic CEO Dario Amodei claimed AI will cure cancer, Alzheimer's and other diseases within a decade in an IPO pitch…
Amodei makes bold disease prediction
In a forty-two-minute IPO roadshow video released on Tuesday, Anthropic CEO Dario Amodei predicted cancer, Alzheimer's, heart disease and mental illness will be cured by AI in less than a decade.
“cancer, Alzheimer's, heart disease, mental illness, these will be relics of the past in, I think, less than a decade.”
Germany's health minister calls timeline impossible
Karl Lauterbach, Germany's former health minister, said on X that curing those diseases in ten years is impossible and questioned whether Amodei knows little about medicine or is deliberately misleading the public.
“Curing cancer, Alzheimer's and mental illnesses can definitely benefit from AI. But that is impossible in just 10 years.”
Researchers say claim lacks substance
Melinda B.Chu, an AI medical researcher with an MD from Saint Louis University, said Amodei made the predictions to stoke hype for the IPO.
“Anthropic has done nothing to suggest they themselves will contribute meaningfully to these goals.”
Biotech executive calls pitch desperate
Rami Elghandour, a biotech executive who has taken two companies public, said Amodei's prediction reeks of desperation and called such claims insane things to say in an IPO pitch.
“I've taken two companies public. These are insane things to say in an IPO pitch and wreaks of desperation.”
Anthropic has expanded into biotech
Anthropic has bought several biotech startups including a one-person company focused on muscular dystrophy treatments. The company opened a wet lab in the Bay Area to explore how AI can support fundamental biology research.
Amodei shifts tone ahead of IPO
In August, Amodei said the best way to win over AI skeptics is to actually cure cancer, but noted that saying AI will cure cancer is a cliché most people think is deceptive.
“saying that AI will cure cancer is more a cliché than it is inspiring, and most people think it is deceptive.”
The key point
Anthropic CEO Dario Amodei claimed AI will cure cancer, Alzheimer's and other diseases within a decade in an IPO pitch, prompting doctors and biotech leaders to question the timeline and accuse him of hype.



